Published in Chest on September 01, 2007
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med (2011) 2.05
Lung cancer: current diagnosis and treatment. Dtsch Arztebl Int (2009) 2.00
Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res (2010) 1.94
Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology (2012) 1.34
Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med (2012) 1.33
Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg (2011) 1.23
Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 1.22
U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prev Med (2010) 1.21
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Gene expression anti-profiles as a basis for accurate universal cancer signatures. BMC Bioinformatics (2012) 1.07
In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. Mol Cell Proteomics (2012) 1.06
Update in lung cancer 2007. Am J Respir Crit Care Med (2008) 1.00
Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging (2010) 0.98
European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol (2011) 0.96
Lung cancer screening: review and performance comparison under different risk scenarios. Lung (2013) 0.94
MicroRNAs - Important Molecules in Lung Cancer Research. Front Genet (2012) 0.90
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC. Oncotarget (2014) 0.90
Cancer screening: the journey from epidemiology to policy. Ann Epidemiol (2012) 0.85
Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res (2009) 0.83
Buccal microRNA dysregulation in lung field carcinogenesis: gender-specific implications. Int J Oncol (2014) 0.79
Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort. BMC Cancer (2011) 0.79
Modeling excess lung cancer risk among screened arm participants in the Mayo Lung Project. Cancer (2010) 0.78
An up to date look at lung cancer screening. Cell Adh Migr (2010) 0.78
Procedures for risk-stratification of lung cancer using buccal nanocytology. Biomed Opt Express (2016) 0.76
Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan. Lung (2012) 0.76
Automated Cell Selection Using Support Vector Machine for Application to Spectral Nanocytology. Biomed Res Int (2016) 0.75
Lung cancer screening: promise and pitfalls. Semin Oncol Nurs (2008) 0.75
PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents. PPAR Res (2008) 0.75
The assessment of the role of baseline low-dose CT scan in patients at high risk of lung cancer. Pol J Radiol (2014) 0.75
Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients. J Thorac Dis (2017) 0.75
Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge. Oncol Lett (2017) 0.75
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Computed tomography screening and lung cancer outcomes. JAMA (2007) 8.01
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med (2002) 5.10
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2014) 4.76
Lung cancer screening with CT: Mayo Clinic experience. Radiology (2003) 4.72
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg (2012) 4.68
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.49
CT screening for lung cancer: five-year prospective experience. Radiology (2005) 4.33
Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.29
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 3.86
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.74
Selection criteria for lung-cancer screening. N Engl J Med (2013) 3.69
Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest (2003) 3.55
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 3.46
Non-small-cell lung cancer. Lancet (2011) 3.45
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology (2007) 3.44
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.36
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 3.36
Pulmonary complications after esophagectomy. Ann Thorac Surg (2002) 3.35
Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.31
Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest (2010) 3.13
Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations. J Thorac Oncol (2012) 3.10
Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest (2012) 2.86
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.83
Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol (2007) 2.79
What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest (2002) 2.79
Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.74
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.72
Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med (2003) 2.71
American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest (2011) 2.61
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.60
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.56
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.47
5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest (2009) 2.45
Grades of recommendation for antithrombotic agents. Chest (2001) 2.44
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol (2003) 2.32
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest (2014) 2.30
Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep (2003) 2.21
Lung cancer screening. Am J Respir Crit Care Med (2015) 2.14
The solitary pulmonary nodule. Chest (2003) 2.09
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
New testing for lung cancer screening. Oncology (Williston Park) (2012) 2.06
Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest (2007) 2.02
Advances in chemotherapy of non-small cell lung cancer. Chest (2006) 2.00
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.00
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 1.99
Intensive care decision making in the seriously ill and elderly. Crit Care Med (2004) 1.98
A prospective multicenter study of competency metrics and educational interventions in the learning of bronchoscopy among new pulmonary fellows. Chest (2009) 1.97
Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med (2001) 1.95
Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.94
One hundred years of lung cancer. Am J Respir Crit Care Med (2005) 1.90
Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.83
Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.81
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.81
Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg (2004) 1.77
Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest (2005) 1.75
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol (2006) 1.75
Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.74
Chemotherapeutic management of stage IV non-small cell lung cancer. Chest (2003) 1.74